JAMA Clinical Reviews podcast

CAR T Cells and T-Cell Therapies for Cancer

0:00
18:22
Spol 15 sekunder tilbage
Spol 15 sekunder frem

CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss "CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review.”

Related Content:

Flere episoder fra "JAMA Clinical Reviews"